Using the Speckle Doppler to Quantify Blood Flow in Kidney and Pancreas Grafts
1 other identifier
observational
8
1 country
1
Brief Summary
Kidney and Pancreas transplantation is considered the treatment of choice for many people with End Stage Renal Disease and Type 1 diabetes because quality of life and survival is often better after transplantation. However the quality of organs varies as does the quality of perfusion once they are transplanted. The immediate determinant of the survival of any transplanted allograft often depends on the overall quality of perfusion of the organ. The assessment of perfusion is currently visually and empirically done and reported by the surgical team, with low objectivity. The Laser Speckle Doppler technique will be used in both kidney and pancreas transplantation to objectively study the quality of blood flow to the kidney and pancreas after transplantation. This Doppler will provide continuous, non-invasive blood flow monitoring of the microvascular environment of the transplanted organ. The strength of the technique is in evaluating changes in flow over an area of interest or the whole transplanted organ and accurately numerically quantifying the flow. The laser speckle Doppler technique is now well established and has been used in various clinical and research setting as the most convenient means of assessing tissue blood flow. It has however not yet been used in kidney and pancreas transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2019
CompletedFirst Submitted
Initial submission to the registry
December 11, 2019
CompletedFirst Posted
Study publicly available on registry
December 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2021
CompletedOctober 5, 2021
October 1, 2021
1.6 years
December 11, 2019
October 4, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the use of the laser blood flow imager in both kidney and pancreas transplantation
Doppler imaging of kidneys and pancreas
3 months
Secondary Outcomes (1)
Measure the markers of inflammation ng/ml Hypo perfusion and oxidative stress (ng/ml) and attempt correlation with the quality of perfusion obtained
6-12 months
Interventions
Eligibility Criteria
This study plans to recruit all recipients of, both kidney and pancreas transplants within a 14-week course of the study (Period of Lease of the Speckle Laser Doppler). It is expected that approximately n=60 kidney transplants (Living Donor, DBD and DCD and Marginal Kidneys) and n=8 pancreas transplant patients will be recruited in this study period. This will provide a range of grafts of varying quality of perfusion for assessment
You may qualify if:
- Kidney Transplant Recipients
- Age between 18 and 75 years
- English Speaking as no funding for translators available
- Able to provide written informed consent
- Receiving a kidney transplant at Manchester University NHS Foundation Trust
- Pancreas Transplant Recipients
- Age between 18 and 75 years
- English Speaking as no funding for translators available
You may not qualify if:
- Outside of stated age range. Aged 76+
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manchester University NHS Foundationn Trust
Manchester, Greater Manchester, M13 9WL, United Kingdom
Related Publications (1)
Gopal JP, Vaz O, Varley R, Spiers H, Goldsworthy MA, Siddagangaiah V, Lock B, Sharma V, Summers A, Moinuddin Z, van Dellen D, Augustine T. Using Laser Speckle Contrast Imaging to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion: A Proof-of-Principle Study. Transplant Direct. 2023 Apr 19;9(5):e1472. doi: 10.1097/TXD.0000000000001472. eCollection 2023 May.
PMID: 37090123DERIVED
Biospecimen
Plasma and cell pellets following blood centrifugation will be collected and stored.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Titus Augustine, FRCS
Manchester university foundation Trust
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2019
First Posted
December 17, 2019
Study Start
December 6, 2019
Primary Completion
July 30, 2021
Study Completion
July 30, 2021
Last Updated
October 5, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share